PharMerica (PharMerica) ROE % Adjusted to Book Value : 1.41% (As of Sep. 2017)

View and export this data going back to 2007. Start your Free Trial

What is PharMerica ROE % Adjusted to Book Value?

PharMerica's ROE % for the quarter that ended in Sep. 2017 was 2.29%. PharMerica's PB Ratio for the quarter that ended in Sep. 2017 was 1.62. PharMerica's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2017 was 1.41%.

PharMerica ROE % Adjusted to Book Value Historical Data

The historical data trend for PharMerica's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharMerica ROE % Adjusted to Book Value Chart

PharMerica Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

5.63

3.05

1.12

3.43

2.86

PharMerica Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															3.42	4.01	1.94	2.31	1.41

Competitive Comparison of PharMerica's ROE % Adjusted to Book Value

For the Medical Distribution subindustry, PharMerica's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharMerica's ROE % Adjusted to Book Value Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PharMerica's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where PharMerica's ROE % Adjusted to Book Value falls into.

PharMerica ROE % Adjusted to Book Value Calculation

PharMerica's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2016 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	4.06%	/	1.42
	=	2.86%

PharMerica's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2017 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	2.29%	/	1.62
	=	1.41%

PharMerica ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of PharMerica's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

PharMerica (PharMerica) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PharMerica Corp (NYSE:PMC) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.pharmerica.com

PharMerica provides pharmacy services to institutional healthcare providers in the United States. The firm has three operating segments: institutional pharmacy, specialty infusion services, and specialty oncology pharmacy. The institutional pharmacy business provides pharmacy products and services to skilled nursing facilities, nursing centers, assisted living facilities, hospitals, and long-term care settings. It purchases, repackages, and dispenses pharmaceuticals and provides on-call pharmacist services to these customers. The specialty infusions segment delivers specialty infusion therapy to patients outside of hospitals and nursing homes. The specialty oncology pharmacy dispenses oncology drugs and provides care management services to patients, oncology practices, and hospitals.

Executives

Marjorie W Dorr	director	ANTHEM INC., 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Gregory S Weishar	director, officer: Chief Executive Officer	ONE CVS DR, WOONSOCKET RI 02895
Geoffrey G Meyers	director	333 NORTH SUMMIT ST, 16TH FLOOR, TOLEDO OH 43604
Robert E. Dries	officer: CFO	701 COOL SPRINGS BOULEVARD FRANKLIN TN 37067
Patrick G Lepore	director	17-17 ROUTE 208 N, FAIRLAWN NJ 07410
Thomas A Caneris	officer: SVP, GC and Secretary	1901 CAMPUS PLACE, LOUISVILLE KY 40299
Froesel David W Jr	officer: Executive VP, CFO & Treasurer
Thomas P Gerrity	director
Mac Mahon Thomas P	director
Daniel Newman Mendelson	director	COVENTRY HEALTH CARE, INC., 6705 ROCKLEDGE DR, SUITE 900, BETHESDA MD 20817
Edward L Kuntz	director
R David Yost	director	1300 MORRIS DRIVE, SUITE 100, CHESTERBROOK PA 19087
Paul J Diaz	director	680 SOUTH FOURTH STREET, LOUISVILLE KY 40202

PharMerica (PharMerica) Headlines

From GuruFocus

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 25,000 Shares

By GuruFocus Research GuruFocus Editor • 11-16-2009

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 81,000 Shares

By GuruFocus Research GuruFocus Editor • 08-13-2010

Weekly CFO Buys Highlight: PMC, ZBB

By gurujk gurujk • 06-25-2012

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 11-04-2010

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 08-05-2010